The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis

Neuroscience Letters

Volumn 343, Issue 2, 2003, Pages 81-84

  Van Damme, Philip ^a   Leyssen, Maarten ^a   Callewaert, Geert ^a   Robberecht, Wim ^a   Van Den Bosch, Ludo ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

AMPA receptor; Amyotrophic lateral sclerosis; Excitotoxicity; Motor neuron; NBQX

Indexed keywords

1,2,3,4 TETRAHYDRO 6 NITRO 2,3 DIOXOBENZO[F]QUINOXALINE 7 SULFONAMIDE; AMPA RECEPTOR ANTAGONIST; EXCITOTOXIN; KAINIC ACID RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CELL CULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG ACTIVITY; EXPERIMENTAL TEST; FAMILIAL DISEASE; IMAGING; MOTONEURON; MOUSE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; SURVIVAL; TRANSGENIC MOUSE;

EID: 0037986558     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00314-8     Document Type: Article

References (24)

1. Bensimon G., Lacomblez L., Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N. Engl. J. Med. 330:1994;585-591.
2. Canton T., Bohme G.A., Boireau A., Bordier F., Mignani S., Jimonet P., Jahn G., Alavijeh M., Stygall J., Roberts S., Brealey C., Vuilhorgne M., Debono M.W., Le Guern S., Laville M., Briet D., Roux M., Stutzmann J.M., Pratt J. RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis. J. Pharmacol. Exp. Ther. 299:2001;314-322.
3. Carriedo S.G., Yin H.Z., Weiss J.H. Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J. Neurosci. 16:1996;4069-4079.
4. Cleveland D.W., Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2:2001;806-819.
5. Feldmeyer D., Kask K., Brusa R., Kornau H.C., Kolhekar R., Rozov A., Burnashev N., Jensen V., Hvalby O., Sprengel R., Seeburg P.H. Neurological dysfunctions in mice expressing different levels of the Q/R site-unedited AMPAR subunit GluR-B. Nat. Neurosci. 2:1999;57-64.
6. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., Chen W., Zhai P., Sufit R.L., Siddique T. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 264:1994;1772-1775.
7. Hugon J., Vallat J.M., Spencer P.S., Leboutet M.J., Barthe D. Kainic acid induces early and delayed degenerative neuronal changes in rat spinal cord. Neurosci. Lett. 104:1989;258-262.
8. Ikonomidou C., Qin Qin Y., Labruyere J., Olney J.W. Motor neuron degeneration induced by excitotoxin agonists has features in common with those seen in the SOD-1 transgenic mouse model of amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 55:1996;211-224.
9. Mennini T., Cagnotto A., Carvelli L., Comoletti D., Manzoni C., Muzio V., Rizzi M., Vezzani A. Biochemical and pharmacological evidence of a functional role of AMPA receptors in motor neuron dysfunction in mnd mice. Eur. J. Neurosci. 11:1999;1705-1710.
10. Perry T.L., Hansen S., Jones K. Brain glutamate deficiency in amyotrophic lateral sclerosis. Neurology. 37:1987;1845-1848.
11. Plaitakis A., Constantakakis E., Smith J. The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis. Ann. Neurol. 24:1988;446-449.
12. Rothstein J.D., Jin L., Dykes-Hoberg M., Kuncl R.W. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl. Acad. Sci. USA. 90:1993;6591-6595.
13. Rothstein J.D., Martin L.J., Kuncl R.W. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 326:1992;1464-1468.
14. Rothstein J.D., Tsai G., Kuncl R.W., Clawson L., Cornblath D.R., Drachman D.B., Pestronk A., Stauch B.L., Coyle J.T. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann. Neurol. 28:1990;18-25.
15. Rothstein J.D., Van Kammen M., Levey A.I., Martin L.J., Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38:1995;73-84.
16. Saroff D., Delfs J., Kuznetsov D., Geula C. Selective vulnerability of spinal cord motor neurons to non-NMDA toxicity. NeuroReport. 11:2000;1117-1121.
17. Shaw P.J., Chinnery R.M., Ince P.G. [3H]D-aspartate binding sites in the normal human spinal cord and changes in motor neuron disease: a quantitative autoradiographic study. Brain Res. 655:1994;195-201.
18. Shaw P.J., Forrest V., Ince P.G., Richardson J.P., Wastell H.J. CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients. Neurodegeneration. 4:1995;209-216.
19. Spencer P.S., Nunn P.B., Hugon J., Ludolph A., Roy D.N. Motorneurone disease on Guam: possible role of a food neurotoxin. Lancet. 1:1986;965.
20. Spencer P.S., Roy D.N., Ludolph A., Hugon J., Dwivedi M.P., Schaumburg H.H. Lathyrism: evidence for role of the neuroexcitatory aminoacid BOAA. Lancet. 2:1986;1066-1067.
21. Takuma H., Kwak S., Yoshizawa T., Kanazawa I. Reduction of GluR2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral sclerosis. Ann. Neurol. 46:1999;806-815.
22. Van Damme P., Van Den Bosch L., Van Houtte E., Eggermont J., Callewaert G., Robberecht W. Na(+) entry through AMPA receptors results in voltage-gated K(+) channel blockade in cultured rat spinal cord motoneurons. J. Neurophysiol. 88:2002;965-972.
23. Van Den Bosch L., Tilkin P., Lemmens G., Robberecht W. Minocycline delays disease onset and mortality in a transgenic model of ALS. NeuroReport. 13:2002;1067-1070.
24. Van Den Bosch L., Vandenberghe W., Klaassen H., Van Houtte E., Robberecht W. Ca(2+)-permeable AMPA receptors and selective vulnerability of motor neurons. J. Neurol. Sci. 180:2000;29-34.